Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies

Maher Albitar, Kim Anh Do, Marcella M. Johnson, Francis J. Giles, Iman Jilani, Susan O'Brien, Jorge Cortes, Deborah Thomas, Laura Z. Rassenti, Thomas J. Kipps, Hagop M. Kantarjian, Michael Keating

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies'. Together they form a unique fingerprint.

Medicine & Life Sciences